198 related articles for article (PubMed ID: 36385375)
1. MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma.
Jin C; Han-Hua D; Qiu-Meng L; Deng N; Peng-Chen D; Jie M; Lei X; Xue-Wu Z; Hui-Fang L; Yan C; Xiao-Ping C; Bi-Xiang Z
Oncogene; 2023 Jan; 42(3):169-183. PubMed ID: 36385375
[TBL] [Abstract][Full Text] [Related]
2. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
[TBL] [Abstract][Full Text] [Related]
3. DDX17 promotes hepatocellular carcinoma progression via inhibiting Klf4 transcriptional activity.
Xue Y; Jia X; Li C; Zhang K; Li L; Wu J; Yuan J; Li Q
Cell Death Dis; 2019 Oct; 10(11):814. PubMed ID: 31653828
[TBL] [Abstract][Full Text] [Related]
4. CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression.
Zhang H; Zou C; Qiu Z; E F; Li Q; Chen M; Wang D; Tan Q; Yin W; Matunda C; Wang H; Zhang Y; Zhan C; Wang C; Wu Y; Xuan X; Wang Y; Zou C; Lv G; Gao X
Cell Death Dis; 2020 Sep; 11(9):792. PubMed ID: 32968053
[TBL] [Abstract][Full Text] [Related]
5. DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis.
Zhou HZ; Li F; Cheng ST; Xu Y; Deng HJ; Gu DY; Wang J; Chen WX; Zhou YJ; Yang ML; Ren JH; Zheng L; Huang AL; Chen J
Hepatology; 2022 Apr; 75(4):847-865. PubMed ID: 34626132
[TBL] [Abstract][Full Text] [Related]
6. HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis.
Dong ML; Wen X; He X; Ren JH; Yu HB; Qin YP; Yang Z; Yang ML; Zhou CY; Zhang H; Cheng ST; Chen J
Front Immunol; 2022; 13():871558. PubMed ID: 35784274
[TBL] [Abstract][Full Text] [Related]
7. Zingerone suppresses proliferation, invasion, and migration of hepatocellular carcinoma cells by the inhibition of MTDH-mediated PI3K/Akt pathway.
Fang J; Zhu H; Xu P; Jiang R
J Recept Signal Transduct Res; 2022 Aug; 42(4):409-417. PubMed ID: 34645355
[TBL] [Abstract][Full Text] [Related]
8. Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway.
Zhu K; Peng Y; Hu J; Zhan H; Yang L; Gao Q; Jia H; Luo R; Dai Z; Tang Z; Fan J; Zhou J
Carcinogenesis; 2020 Apr; 41(2):130-138. PubMed ID: 31498866
[TBL] [Abstract][Full Text] [Related]
9. Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.
Yang L; He K; Yan S; Yang Y; Gao X; Zhang M; Xia Z; Huang Z; Huang S; Zhang N
Neuro Oncol; 2017 Mar; 19(3):352-363. PubMed ID: 27923917
[TBL] [Abstract][Full Text] [Related]
10. Metadherin-driven promotion of cancer stem cell phenotypes and its effect on immunity in hepatocellular carcinoma.
Todorović N; Amedei A
World J Gastroenterol; 2024 May; 30(20):2624-2628. PubMed ID: 38855151
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
12. T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
Ji X; Chen X; Zhang B; Xie M; Zhang T; Luo X; Liu D; Feng Y; Wang Y; Sun M; Li C; Huang W; Xia L
Oncogene; 2022 Apr; 41(15):2225-2238. PubMed ID: 35217793
[TBL] [Abstract][Full Text] [Related]
13. Expression of metadherin/AEG-1 gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials.
Zhou Z; Deng H; Yan W; Huang H; Deng Y; Li Y; Tian D
J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):353-357. PubMed ID: 22684557
[TBL] [Abstract][Full Text] [Related]
14. TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.
Xia S; Ji L; Tao L; Pan Y; Lin Z; Wan Z; Pan H; Zhao J; Cai L; Xu J; Cai X
Cell Mol Gastroenterol Hepatol; 2021; 12(3):1121-1143. PubMed ID: 33962073
[TBL] [Abstract][Full Text] [Related]
15. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
Zhang M; Li M; Li N; Zhang Z; Liu N; Han X; Liu Q; Liao C
Oncol Rep; 2017 Mar; 37(3):1772-1778. PubMed ID: 28184926
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin.
Jia C; Tang D; Sun C; Yao L; Li F; Hu Y; Zhang X; Wu D
Oncol Rep; 2018 Dec; 40(6):3890-3898. PubMed ID: 30542714
[TBL] [Abstract][Full Text] [Related]
17. The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway.
Song J; Liu Y; Liu F; Zhang L; Li G; Yuan C; Yu C; Lu X; Liu Q; Chen X; Liang H; Ding Z; Zhang B
Theranostics; 2021; 11(3):996-1015. PubMed ID: 33391517
[TBL] [Abstract][Full Text] [Related]
18. AEG-1/MTDH/LYRIC in liver cancer.
Sarkar D
Adv Cancer Res; 2013; 120():193-221. PubMed ID: 23889992
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Repression of Raf Kinase Inhibitory Protein Gene by Metadherin during Cancer Progression.
Lai TH; Ahmed M; Hwang JS; Zada S; Pham TM; Elashkar O; Kim DR
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802672
[TBL] [Abstract][Full Text] [Related]
20. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.
Zhou H; Du Y; Wei X; Song C; Song J; Xu N; Huang W; Chen L; Yao F; Du D; Qiu C; Zhong L; Liu Y; Gu D; Wang J; Xu Y
Theranostics; 2022; 12(14):6069-6087. PubMed ID: 36168636
[No Abstract] [Full Text] [Related]
[Next] [New Search]